India Schedule H2 QR rules tighten vaccine pack coding
G.S.R. 506(E) of 22 June 2026 expands Schedule H2 QR traceability to vaccines, NDPS, and anticancer drugs from 1 July 2027, with antimicrobials deferred to 1 July 2028.
What changed
On 22 June 2026 the Ministry of Health and Family Welfare notified the Drugs (Seventh Amendment) Rules, 2026 via G.S.R. 506(E), inserting Table 2 into Schedule H2 of the Drugs Rules, 1945 to cover all vaccines, all antimicrobials, all NDPS-listed narcotic and psychotropic formulations, and all anticancer drugs for barcode/QR track-and-trace on primary—or where space is insufficient, secondary—packaging.
The rules come into force on 1 July 2027 for vaccines, NDPS, and anticancer drugs; serial number 2 (all antimicrobials) is deferred to 1 July 2028. Industry estimate: Indian MAH and CMO artwork freezes for vaccine and oncology packs need 9–15 months of printer, verifier, and repository integration before the 1 July 2027 mandatory day, so installation cutoffs must clear mid-2026 to early-2027 validation gates—not the 1 July 2027 first mandatory day itself.
Products affected
Primary map: QR/barcode print-and-verify modules for primary and secondary packs, vision inspection cameras for Schedule H2 lines, and serialization software links used by vaccine, oncology, and NDPS manufacturers—aggregation remains a commercial line choice, not the Schedule H2 hard mandate.
Buyer segments to prioritize
Prioritize MAH packaging engineering leads and CMO serialization project managers in Maharashtra and Telangana writing QR transition RFQs for vaccine and anticancer lines ahead of 1 July 2027; packaging-line OEMs are RFQ respondents, not the RFQ writers.
Exporter action
Lead with IQ/OQ/PQ protocols for GS1-compatible QR print-verify-reject, sample packs sized for CDSCO inspection readiness, and installation slots that clear validation before 1 July 2027 for vaccines/NDPS/oncology—antimicrobial lines may stage to the 1 July 2028 gate.
Source context
Primary source: Ministry of Health and Family Welfare, G.S.R. 506(E), Drugs (Seventh Amendment) Rules, 2026, 22 June 2026 (force from 1 July 2027; antimicrobials from 1 July 2028). https://thehealthmaster.com/wp-content/uploads/2024/11/GSR-506E-dt-22-06-2026-Notification-regarding-Schedule-H2-drugs-insertion-of-Table-1-and-Table-2-regarding-Vaccines-Antimicrobials-NDPS-and-Anticancer-drugs.pdf Secondary English reporting: The Hindu, 26 June 2026. https://www.thehindu.com/news/national/health-ministry-expands-qr-code-based-drug-traceability-to-vaccines-antimicrobials-and-cancer-medicines/article71146237.ece Where paraphrase conflicts with the Gazette text, G.S.R. 506(E) prevails. This article is original TradeSignal analysis, not a republication of third-party news copy.
Key takeaways
- G.S.R. 506(E) mandates Schedule H2 QR for vaccines, NDPS, and anticancer drugs from 1 July 2027; antimicrobials from 1 July 2028.
- Outreach: MAH and CMO packaging leads in Maharashtra and Telangana validating print-verify paths before the 1 July 2027 gate.
Industry hubs
Pillar pages for the product categories in this signal.
Want buyer matches tied to this signal?
TradeSignal connects market events to buyer segments, product context, and outreach timing.
Book a demo